Finance

Lists
NUS:NYSE
NU Skin Enterprises Inc
USD 4,68
+0,75%
(+0,035) 1D
29 Sep., 15:35:33 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NUS...
Open
USD 4,65
High
USD 4,73
Low
USD 4,63
Mkt. cap
227,56 m
Avg. vol.
518,44 k
Volume
211,68 k
Dividend
5,13%
Quarterly dividend
USD 0,06
Ex-dividend date
28 Aug. 2026
52-wk high
USD 12,26
52-wk low
USD 4,49
EPS
-USD 4,48
Beta
0,97
Shares outstanding
48,68 m
No. of employees
3 k
Open
USD 4,65
High
USD 4,73
Low
USD 4,63
Mkt. cap
227,56 m
Avg. vol.
518,44 k
Volume
211,68 k
Dividend
5,13%
Quarterly dividend
USD 0,06
Ex-dividend date
28 Aug. 2026
52-wk high
USD 12,26
52-wk low
USD 4,49
EPS
-USD 4,48
Beta
0,97
Shares outstanding
48,68 m
No. of employees
3 k
News stories
From web sources and news partners
Profile
Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors. The company was founded in 1984 by Blake Roney, Nedra Roney, Sandie Tillotson, and Steven J. Lund. Wikipedia
About NU Skin Enterprises Inc
CEORyan Napierski
Employees2,8 k
Founded1984
HeadquartersProvo, Utah, Verenigde State van Amerika
SectorPersonal care products
Websitenuskin.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Last report
10 Aug. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
USD 0,20 / USD 0,20
0,00%miss
Revenue / Est. (USD)
320,11 m / 345,20 m
-7,27%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
364,21 m
370,32 m
320,61 m
320,11 m
Cost of goods sold
107,49 m
108,34 m
106,14 m
101,79 m
Cost of revenue
107,49 m
108,34 m
106,14 m
101,79 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
235,08 m
238,74 m
208,60 m
198,77 m
Operating expense
235,08 m
238,74 m
208,60 m
198,77 m
Total operating expenses
342,57 m
347,08 m
314,74 m
300,56 m
Operating income
21,64 m
23,24 m
5,86 m
19,56 m
Other non operating income
26,57 m
-29,14 m
2,82 m
-534,00 k
EBT including unusual items
15,99 m
18,19 m
2,60 m
-63,18 m
EBT excluding unusual items
44,07 m
-9,89 m
4,44 m
15,70 m
Income tax expense
-1,08 m
3,70 m
763,00 k
186,62 m
Effective tax rate
-6,78%
20,34%
29,36%
-295,41%
Other operating expenses
-
-
-
-
Net income
17,08 m
14,49 m
1,84 m
-249,80 m
Net profit margin
4,69%
3,91%
0,57%
-78,03%
Earnings per share
0,34
0,29
0,14
0,20
Interest and investment income
-
-
-
-
Interest expense
-4,14 m
-3,99 m
-4,25 m
-3,32 m
Net interest expenses
-4,14 m
-3,99 m
-4,25 m
-3,32 m
Depreciation and amortization charges
-
-
-
-
EBITDA
33,73 m
36,16 m
18,21 m
32,21 m
Gain or loss from assets sale
243,00 k
-11,00 k
303,00 k
-10,00 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme